Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07786662
PHASE3

Early Corticosteroids in Severe Influenza Pneumonia

Sponsor: Centre Hospitalier Régional Metz-Thionville

View on ClinicalTrials.gov

Summary

This is a Phase III, multicentre, randomized, controlled, double-blind, superiority trial aiming to evaluate the efficacy of dexamethasone versus placebo in patients admitted to intensive care or intermediate care with influenza and hypoxemic acute respiratory failure. Patients will receive state-of-the-art standard therapy for severe influenza. They will be randomized in a 1:1 ratio to one of the two arms. Patients, investigators and care providers will be blinded to the patient arm. Patients will receive antiviral treatment and antibiotic therapy if bacterial co-infection is suspected. All clinical interventions such as use of ventilatory strategy, laboratory tests, and hemodynamic management will be left at the discretion of the team in both arms. Special attention will be given to the prompt diagnosis and management of aspergillosis, with investigators provided with decision support tools and algorithms based on the most recent definition (i.e., FUNDICU). Patients will be followed for up to 28 days after enrolment and national registries will be used for 90-day vital status assessment. Telephone calls will be made on day 90 to assess quality of life.

Official title: Early Corticosteroids in Severe Influenza Pneumonia, a Phase III Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

544

Start Date

2026-09

Completion Date

2029-12

Last Updated

2026-08-26

Healthy Volunteers

No

Interventions

DRUG

treatment administration

Experimental Group : A daily dose of 6 mg dexamethasone (investigational medicinal product) suspended in sodium chloride 0.9% and administered as a masked intravenous injection (total volume of 5 ml) once daily for up to 10 days from randomization OR until discharge from the participating intensive care or intermediate care unit. Placebo : A daily dose of placebo (sodium chloride 0.9%, total volume of 5 ml) intravenously once daily for up to 10 days from randomization OR until discharge from the participating intensive care or intermediate care unit.

Locations (48)

CH Argenteuil - Victor Dupouy

Argenteuil, France

APHP - Hôpital Avicenne

Bobigny, France

CH Bourg-en-Bresse - Fleyriat

Bourg-en-Bresse, France

CHU de Caen Normandie - Hôpital Côte de Nacre

Caen, France

CH de Cannes - Simone Veil

Cannes, France

Centre Hospitalier Public du Cotentin

Cherbourg, France

APHP - Hôpital Louis Mourier

Colombes, France

APHP - Hôpital Henri Mondor

Créteil, France

CHU de Dijon Bourgogne

Dijon, France

CH Annecy Genevois - Site Annecy

Épagny, France

CH Joséphine Backer - Site Gonesse

Gonesse, France

CH de Haguenau

Haguenau, France

Centre Hospitalier Départemental Vendée - Site La Roche-Sur-Yon

La Roche-sur-Yon, France

Groupe Hospitalier la Rochelle-Ré-Aunis - Hôpital de La Rochelle

La Rochelle, France

CH de Versailles - Site André Mignot

Le Chesnay, France

CH Le Mans

Le Mans, France

CHU de Lille - Hôpital Roger SALENGRO

Lille, France

Groupe Hospitalier Bretagne Sud - Hôpital du Scorff

Lorient, France

HCL - Hôpital de la Croix-Rousse

Lyon, France

HCL - Hôpital Edouard Herriot

Lyon, France

APHM - Hôpital de la Timone

Marseille, France

Institut Paoli-Calmettes

Marseille, France

APHM - CHU Nord

Marseille, France

GH Sud-Ile de France - CH de Melun-Sénart

Melun, France

CHR Metz-Thionville, Hopital de Mercy

Metz, France

GH Portes de Provence - Hôpital de Montélimar

Montélimar, France

CHU de Montpellier - Hôpital Saint Eloi

Montpellier, France

CHRU de Nancy - Hôpital Central

Nancy, France

CHU de Nantes - Hôtel Dieu

Nantes, France

Groupe Hospitalier Privé Ambroise Paré-Hartmann - Hôpital Ambroise Paré

Neuilly-sur-Seine, France

CHU de Nîmes - Hôpital Caremeau

Nîmes, France

CHU d'Orléans

Orléans, France

APHP - Hôpital Cochin

Paris, France

APHP - Groupe Hospitalier Bichat - Claude Bernard

Paris, France

CHI de Poissy Saint-Germain-en-Laye - Site Hospitalier de Poissy

Poissy, France

CHU de Poitiers - Site de la Milétrie

Poitiers, France

CHU de Rennes - Hôpital Pontchaillou

Rennes, France

CH de Saint-Brieuc, Paimpol et Tréguier - Hôpital de Saint-Brieuc

Saint-Brieuc, France

CH de Saint-Nazaire

Saint-Nazaire, France

Groupe Hospitalier Rance Emeraude - Site Hospitalier Broussais

St-Malo, France

CHRU de Strasbourg - Hôpital de Hautepierre

Strasbourg, France

CHR Metz-Thionville, Hôpital Bel Air

Thionville, France

CH de Tourcoing - Hôpital Chatiliez

Tourcoing, France

Hôpital Nord Franche Comté - Site Trévenans

Trévenans, France

CH de Valence

Valence, France

CHRU de Nancy - Hôpitaux de Brabois

Vandœuvre-lès-Nancy, France

CH Bretagne Atlantique - Site Vannes

Vannes, France

Hôpitaux Privés de Metz - Hôpital Robert Schuman

Vantoux, France